L-Asparaginase (Asparaginesaminohydrolase E.C.3.5.1.1) are one of the most significant collection of restorative enzymes accounting about 40% of the global marketable enzymes for therapy. Global requirements of anti leukemic and anti-lymphoma agents are far greater than those of other therapeutic enzymes of which Asparaginase contribute one third. This enzymes has been always in a high demand with shortfall in production from different pharmaceutical companies as the genetic expression of L-Asparginase enzyme production is slow and low as well. As production rate is low, the cost of enzyme is...